FR2184898B1 - - Google Patents

Info

Publication number
FR2184898B1
FR2184898B1 FR7317649A FR7317649A FR2184898B1 FR 2184898 B1 FR2184898 B1 FR 2184898B1 FR 7317649 A FR7317649 A FR 7317649A FR 7317649 A FR7317649 A FR 7317649A FR 2184898 B1 FR2184898 B1 FR 2184898B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7317649A
Other languages
French (fr)
Other versions
FR2184898A1 (ja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Laboratories Inc filed Critical Baxter Laboratories Inc
Publication of FR2184898A1 publication Critical patent/FR2184898A1/fr
Application granted granted Critical
Publication of FR2184898B1 publication Critical patent/FR2184898B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Golf Clubs (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Medicinal Preparation (AREA)
FR7317649A 1972-05-17 1973-05-16 Expired FR2184898B1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00254148A US3803115A (en) 1972-05-17 1972-05-17 Stabilization of ahf using heparin

Publications (2)

Publication Number Publication Date
FR2184898A1 FR2184898A1 (ja) 1973-12-28
FR2184898B1 true FR2184898B1 (ja) 1976-11-05

Family

ID=22963114

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7317649A Expired FR2184898B1 (ja) 1972-05-17 1973-05-16

Country Status (18)

Country Link
US (2) US3803115A (ja)
JP (1) JPS596845B2 (ja)
AT (1) AT344881B (ja)
AU (1) AU465351B2 (ja)
BE (1) BE799525A (ja)
CA (1) CA1007986A (ja)
CH (1) CH630804A5 (ja)
DE (1) DE2324717C3 (ja)
DK (1) DK136016B (ja)
ES (1) ES414823A1 (ja)
FR (1) FR2184898B1 (ja)
GB (1) GB1372515A (ja)
IL (1) IL42221A (ja)
IT (1) IT1061433B (ja)
NL (1) NL7306806A (ja)
NO (1) NO142381C (ja)
SE (1) SE430020B (ja)
ZA (1) ZA733138B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388232A (en) 1979-04-19 1983-06-14 Immuno Aktiengesellschaft Fur Chemisch Medizinische Produkte Method of producing plasma fractions free of side-effects using fast-reacting antithrombin

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3920625A (en) * 1973-06-19 1975-11-18 Kabi Ab Isolation of coagulation factors from biological material using cross linked sulfated, sulfonated carbohydrates
US4022758A (en) * 1973-06-19 1977-05-10 Ab Kabi Isolation of coagulation factors I and VIII from biological material
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4089944A (en) 1975-12-22 1978-05-16 Baxter Travenol Laboratories, Inc. Rapidly solubilized AHF composition and process for preparing same
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1074698A (en) * 1977-12-19 1980-04-01 Gail A. Rock Method of collecting anti-hemophilic factor viii from blood and blood plasma
US4210580A (en) * 1979-06-19 1980-07-01 David Amrani Process for separation and isolation of AHF and fibronectin from blood plasma
US4278594A (en) * 1979-06-19 1981-07-14 David Amrani Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
EP0033582B1 (en) * 1980-01-18 1984-04-11 The Canadian Red Cross Society Method of obtaining factor viii
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
CA1178887A (en) * 1981-10-01 1984-12-04 Gail A. Rock Factor viii concentrates prepared from heparinized plasma by the application of a cold precipitation technique
US4397841A (en) 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4543210A (en) 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
EP0238701B1 (de) * 1986-03-27 1992-03-18 Octapharma AG Verfahren zur Herstellung eines hochgereinigten Antihämophilie-Faktors
USH1509H (en) * 1989-06-09 1995-12-05 Eran; Harutyun Heparin enhanced process for separating antihemophilic factor (Factor VIII) and fibronectin from cryoprecipitate
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
FR2657884B1 (fr) * 1990-02-05 1994-09-02 Tm Innovation Procede pour la preparation du facteur viii humain et d'analogues du facteur viii.
IT1248723B (it) * 1990-06-12 1995-01-26 Scalvo S P A Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US8389687B2 (en) * 2000-10-23 2013-03-05 Shanbrom Technologies, Llc Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors
US6881731B1 (en) * 2000-10-23 2005-04-19 Shanbrom Technologies, Llc Enhancers for microbiological disinfection
US7411006B2 (en) * 2000-10-23 2008-08-12 Shanbrom Technologies, Llc Enhanced production of blood clotting factors and fibrin fabric
US7297716B2 (en) * 2000-10-23 2007-11-20 Shanbrom Technologies, Llc Enhanced production of blood components, blood cells and plasma without freezing
CA2438223A1 (en) * 2001-02-07 2002-11-07 Shanbrom Technologies, Llc Carboxylic acid such as citric acid for desinfecting or enhacing the production of blood products such as plasma, cryoprecipitate or/and platelet

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2867567A (en) * 1955-01-21 1959-01-06 Nat Res Dev Process of preparing anti-haemophilic globulin
DE1949314U (de) 1966-05-07 1966-11-10 Braun Fa B Bohrdraht-bereitschaftskasten.
BE713764A (ja) 1967-05-01 1968-09-16 Baxter Travenol Lab
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3560475A (en) * 1969-06-19 1971-02-02 Baxter Laboratories Inc Prothrombin complex prepared by precipitation with polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388232A (en) 1979-04-19 1983-06-14 Immuno Aktiengesellschaft Fur Chemisch Medizinische Produkte Method of producing plasma fractions free of side-effects using fast-reacting antithrombin

Also Published As

Publication number Publication date
IL42221A0 (en) 1973-07-30
DE2324717A1 (de) 1973-12-13
ATA433573A (de) 1975-04-15
DK136016B (da) 1977-08-01
GB1372515A (en) 1974-10-30
SE430020B (sv) 1983-10-17
JPS4956695A (ja) 1974-06-01
DE2324717B2 (de) 1980-01-03
CH630804A5 (de) 1982-07-15
USRE29698E (en) 1978-07-11
ES414823A1 (es) 1976-02-01
JPS596845B2 (ja) 1984-02-15
IT1061433B (it) 1983-02-28
BE799525A (fr) 1973-08-31
AU5584973A (en) 1974-11-21
IL42221A (en) 1977-04-29
DE2324717C3 (de) 1983-12-01
FR2184898A1 (ja) 1973-12-28
AU465351B2 (en) 1975-09-25
ZA733138B (en) 1974-03-27
NO142381C (no) 1980-08-13
CA1007986A (en) 1977-04-05
DK136016C (ja) 1978-01-02
US3803115A (en) 1974-04-09
NO142381B (no) 1980-05-05
AT344881B (de) 1978-08-10
NL7306806A (ja) 1973-11-20

Similar Documents

Publication Publication Date Title
DK136016C (ja)
JPS496141A (ja)
FR2208906B1 (ja)
FR2211467B1 (ja)
JPS4891316U (ja)
JPS5142555B2 (ja)
JPS48104218U (ja)
JPS4997388U (ja)
JPS495090U (ja)
JPS4928731U (ja)
CH582166A5 (ja)
CH582986A5 (ja)
CH1809873A4 (ja)
CH581224A5 (ja)
CH561786A5 (ja)
CH605725A5 (ja)
CH1668773A4 (ja)
CH580678A5 (ja)
CH580570A5 (ja)
CH582395A5 (ja)
BG22072A3 (ja)
CH593329A5 (ja)
BG19428A1 (ja)
BG18499A1 (ja)
NL7203264A (ja)

Legal Events

Date Code Title Description
CD Change of name or company name
CD Change of name or company name